This is the 18th week of continual falls. Just checked my charts and there are no signals AT ALL of a change in direction. This stock is being heavily impacted by poor sentiment and the fact the business was not prepared to forecast future earnings. At this rate the knife is gaining pace and wouldn't be surprised if we are back to 90c before the end of May. No solid support levels evident in the charts post COVID fall at todays close price. DYOR
- Forums
- ASX - By Stock
- AX1
- Ann: Business Update
Ann: Business Update, page-52
Featured News
Add AX1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.45 |
Change
0.110(4.70%) |
Mkt cap ! $1.386B |
Open | High | Low | Value | Volume |
$2.35 | $2.46 | $2.34 | $3.609M | 1.489M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 501 | $2.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.46 | 53949 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 501 | 2.440 |
6 | 22062 | 2.430 |
3 | 7323 | 2.420 |
3 | 17031 | 2.410 |
2 | 7083 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.460 | 53949 | 6 |
2.470 | 64492 | 7 |
2.480 | 25942 | 4 |
2.490 | 76270 | 8 |
2.500 | 64594 | 17 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AX1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online